A Nasal Spray Called Neffy Has Been Approved By Fda

Canadians Now Have Affordable and Safe Alternative to Epipen

A Nasal Spray Called Neffy Has Been Approved by FDA

Canadians with severe food allergies now have an alternative to the EpiPen, which has been plagued by shortages and price increases. Health Minister Ginette Petitpas Taylor has signed an interim order to allow the US-approved Auvi-Q epinephrine auto-injector to be sold in Canada.

Cost-Effective and Safe Alternative

The Auvi-Q is a single-use auto-injector that delivers a life-saving dose of epinephrine in case of a severe allergic reaction. It is comparable to the EpiPen in terms of effectiveness and safety, but it is significantly more affordable.

ARS Pharma's Neffy

Another alternative to the EpiPen is a nasal epinephrine spray called Neffy, produced by ARS Pharma. Neffy has been approved by the FDA and is available in the United States. It is a non-invasive and easy-to-use nasal spray that delivers a precise dose of epinephrine.

Neffy's Advantages and Availability

Neffy has several advantages over the EpiPen, including its ease of use, affordability, and extended shelf life. It is especially beneficial for individuals who may have difficulty using an auto-injector or for those who experience multiple allergic reactions.

While Neffy is not yet available in Canada, it is expected to be approved and available in the near future. This will provide Canadians with more affordable and accessible options for managing their severe food allergies.